These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27938583)
1. [Meta-analysis: somatostatin for prophylaxis against post endoscopic retrograde cholangiopancreatography pancreatitis]. Pan SB; Geng XP Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):466-472. PubMed ID: 27938583 [No Abstract] [Full Text] [Related]
2. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. Omata F; Deshpande G; Tokuda Y; Takahashi O; Ohde S; Carr-Locke DL; Jacobs JL; Mine T; Fukui T J Gastroenterol; 2010 Aug; 45(8):885-95. PubMed ID: 20373114 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis. Qin X; Lei WS; Xing ZX; Shi F Saudi J Gastroenterol; 2015; 21(6):372-8. PubMed ID: 26655132 [TBL] [Abstract][Full Text] [Related]
4. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial. Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398 [TBL] [Abstract][Full Text] [Related]
5. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review. Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214 [TBL] [Abstract][Full Text] [Related]
6. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959 [TBL] [Abstract][Full Text] [Related]
7. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis. Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097 [TBL] [Abstract][Full Text] [Related]
8. Post-ERCP pancreatitis. Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459 [TBL] [Abstract][Full Text] [Related]
10. [Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, non-randomized study]. Vila JJ; Jiménez FJ; Prieto C; Borobio E; Juanmartiñena JF; Borda F Gastroenterol Hepatol; 2006 Apr; 29(4):231-6. PubMed ID: 16584693 [TBL] [Abstract][Full Text] [Related]
11. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762 [TBL] [Abstract][Full Text] [Related]
12. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. Rudin D; Kiss A; Wetz RV; Sottile VM J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Andriulli A; Leandro G; Niro G; Mangia A; Festa V; Gambassi G; Villani MR; Facciorusso D; Conoscitore P; Spirito F; De Maio G Gastrointest Endosc; 2000 Jan; 51(1):1-7. PubMed ID: 10625786 [TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665 [TBL] [Abstract][Full Text] [Related]
15. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Lyu Y; Cheng Y; Wang B; Xu Y; Du W BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142 [TBL] [Abstract][Full Text] [Related]
16. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Bordas JM; Toledo-Pimentel V; Llach J; Elena M; Mondelo F; Ginès A; Terés J Gastrointest Endosc; 1998 Mar; 47(3):230-4. PubMed ID: 9540874 [TBL] [Abstract][Full Text] [Related]
17. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Lee KT; Lee DH; Yoo BM Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial. Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178 [TBL] [Abstract][Full Text] [Related]
19. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776 [TBL] [Abstract][Full Text] [Related]